↓ Skip to main content

Engineered PLGA microspheres for extended-release of naltrexone: in vitro, in vivo, and IVIVR

Overview of attention for article published in Pharmaceutical Development & Technology, January 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Readers on

mendeley
6 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Engineered PLGA microspheres for extended-release of naltrexone: in vitro, in vivo, and IVIVR
Published in
Pharmaceutical Development & Technology, January 2023
DOI 10.1080/10837450.2023.2172041
Pubmed ID
Authors

Maryam Ghareh Sheikhlou, Nazanin Shabani Ravari, Milad Behrouzi, Navid Goodarzi, Roshana Saghafian Larijani, Reyhaneh Varshochian, Rassoul Dinarvand, Mohammad Reza Rouini

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 17%
Professor 1 17%
Unknown 4 67%
Readers by discipline Count As %
Unspecified 1 17%
Pharmacology, Toxicology and Pharmaceutical Science 1 17%
Unknown 4 67%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 January 2023.
All research outputs
#15,532,577
of 25,392,582 outputs
Outputs from Pharmaceutical Development & Technology
#394
of 610 outputs
Outputs of similar age
#215,098
of 473,262 outputs
Outputs of similar age from Pharmaceutical Development & Technology
#2
of 6 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 610 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 473,262 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.